Antineoplastic activity of parvoviruses
1Department of Molecular Biology, Université Libre de Bruxelles, Rhode-Saint-Genèse, Belgium.
Journal of Virological Methods
|August 1, 1991
Summary
Certain parvoviruses show significant antineoplastic activity by inhibiting tumor formation and growth in animals. These viruses may offer new strategies for cancer research and treatment due to their oncotropic nature.
Area of Science:
- Virology
- Oncology
- Molecular Biology
Background:
- Parvoviridae are small, non-enveloped viruses with single-stranded DNA genomes that replicate in the nucleus.
- Certain parvoviruses exhibit potent antineoplastic properties against spontaneous and induced tumors in animal models.
- Epidemiological studies suggest a link between parvoviral infections and reduced cancer incidence in humans.
Purpose of the Study:
- To investigate the oncotropic and antineoplastic potential of parvoviruses.
- To explore the mechanisms underlying parvovirus-mediated tumor inhibition.
- To assess the utility of parvoviruses in cancer research.
Main Methods:
- In vivo studies using laboratory animals to assess tumor prevention and inhibition.
- In vitro studies on established tumor cells to evaluate cytotoxic and cytostatic effects.
- Analysis of parvoviral life cycle dependency on cellular proliferation and differentiation factors.
Main Results:
- Parvoviruses effectively inhibit the formation and growth of various tumors in animals.
- Established cancer cells are targeted by parvoviruses, showing inhibited growth.
- In vitro studies reveal preferential lysis and transformation reversion of neoplastic cells by parvoviruses.
- Parvoviruses can down-modulate oncogene expression and stimulate cytotoxic viral proteins.
Conclusions:
- Parvoviruses possess significant oncosuppressive activity through direct effects on neoplastic cells.
- Viral oncotropism is linked to their dependence on cellular proliferation and differentiation.
- Parvoviruses may serve as valuable tools for studying malignant transformation and developing novel cancer therapies.
Related Concept Videos
02:04Co-activators and Co-repressors
8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
02:26tRNA Activation
23.1K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.1K
01:26Activation Energy
87.0K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
87.0K
02:42Eukaryotic Transcription Activators
12.9K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.9K
01:55Secondary Active Transport
138.1K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
138.1K
01:47Primary Active Transport
200.7K
In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
200.7K